Avantor, Inc. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
Avantor, Inc. (AVTR) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $9.00 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-04-29
- Avantor, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $9.00M, a 30.77% decline year-over-year.
- Avantor, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-12-31 was $11.40M, a 2.56% decline year-over-year.
- Avantor, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $7.40M, a 34.51% decline year-over-year.
- Avantor, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $15.80M, a 36.21% increase year-over-year.
- Avantor, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $47.60M, a 1.28% increase from fiscal 2024.
- Avantor, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $47.00M, a 16.92% increase from fiscal 2023.
- Avantor, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $40.20M, a 18.13% decline from fiscal 2022.
- Avantor, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $49.10M, a 2.94% increase from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-03-31 | $9.00M 10-Q · filed 2026-04-29 | $20.40M derived: sum of 2 quarters · filed 2026-04-29 | $27.80M derived: sum of 3 quarters · filed 2026-04-29 | $43.60M derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-12-31 | $11.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $18.80M derived: sum of 2 quarters · filed 2026-02-11 | $34.60M derived: sum of 3 quarters · filed 2026-02-11 | $47.60M 10-K · filed 2026-02-11 |
| 2025-09-30 | $7.40M 10-Q · filed 2025-10-29 | $23.20M derived: sum of 2 quarters · filed 2025-10-29 | $36.20M 10-Q · filed 2025-10-29 | $47.90M derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-06-30 | $15.80M 10-Q · filed 2025-08-01 | $28.80M 10-Q · filed 2025-08-01 | $40.50M derived: sum of 3 quarters · filed 2026-04-29 | $51.80M derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-03-31 | $13.00M 10-Q · filed 2026-04-29 | $24.70M derived: sum of 2 quarters · filed 2026-04-29 | $36.00M derived: sum of 3 quarters · filed 2026-04-29 | $47.60M derived: sum of 4 quarters · filed 2026-04-29 |
| 2024-12-31 | $11.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $23.00M derived: sum of 2 quarters · filed 2026-02-11 | $34.60M derived: sum of 3 quarters · filed 2026-02-11 | $47.00M 10-K · filed 2026-02-11 |
| 2024-09-30 | $11.30M 10-Q · filed 2025-10-29 | $22.90M derived: sum of 2 quarters · filed 2025-10-29 | $35.30M 10-Q · filed 2025-10-29 | $43.90M derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-06-30 | $11.60M 10-Q · filed 2025-08-01 | $24.00M 10-Q · filed 2025-08-01 | $32.60M derived: sum of 3 quarters · filed 2026-02-11 | $42.30M derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-03-31 | $12.40M 10-Q · filed 2025-04-25 | $21.00M derived: sum of 2 quarters · filed 2026-02-11 | $30.70M derived: sum of 3 quarters · filed 2026-02-11 | $40.00M derived: sum of 4 quarters · filed 2026-02-11 |
| 2023-12-31 | $8.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $18.30M derived: sum of 2 quarters · filed 2026-02-11 | $27.60M derived: sum of 3 quarters · filed 2026-02-11 | $40.20M 10-K · filed 2026-02-11 |
| 2023-09-30 | $9.70M 10-Q · filed 2024-10-25 | $19.00M derived: sum of 2 quarters · filed 2024-10-25 | $31.60M 10-Q · filed 2024-10-25 | $41.60M derived: sum of 4 quarters · filed 2025-02-07 |
| 2023-06-30 | $9.30M 10-Q · filed 2024-07-26 | $21.90M 10-Q · filed 2024-07-26 | $31.90M derived: sum of 3 quarters · filed 2025-02-07 | $45.60M derived: sum of 4 quarters · filed 2025-02-07 |
| 2023-03-31 | $12.60M 10-Q · filed 2024-04-26 | $22.60M derived: sum of 2 quarters · filed 2025-02-07 | $36.30M derived: sum of 3 quarters · filed 2025-02-07 | $49.70M derived: sum of 4 quarters · filed 2025-02-07 |
| 2022-12-31 | $10.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-07 | $23.70M derived: sum of 2 quarters · filed 2025-02-07 | $37.10M derived: sum of 3 quarters · filed 2025-02-07 | $49.10M 10-K · filed 2025-02-07 |
| 2022-09-30 | $13.70M 10-Q · filed 2023-10-27 | $27.10M derived: sum of 2 quarters · filed 2023-10-27 | $39.10M 10-Q · filed 2023-10-27 | $52.60M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-06-30 | $13.40M 10-Q · filed 2023-07-28 | $25.40M 10-Q · filed 2023-07-28 | $38.90M derived: sum of 3 quarters · filed 2024-02-14 | $50.80M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-03-31 | $12.00M 10-Q · filed 2023-04-28 | $25.50M derived: sum of 2 quarters · filed 2024-02-14 | $37.40M derived: sum of 3 quarters · filed 2024-02-14 | $48.90M derived: sum of 4 quarters · filed 2024-02-14 |
| 2021-12-31 | $13.50M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $25.40M derived: sum of 2 quarters · filed 2024-02-14 | $36.90M derived: sum of 3 quarters · filed 2024-02-14 | $47.70M 10-K · filed 2024-02-14 |
| 2021-09-30 | $11.90M 10-Q · filed 2022-10-28 | $23.40M derived: sum of 2 quarters · filed 2022-10-28 | $34.20M 10-Q · filed 2022-10-28 | $46.30M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-06-30 | $11.50M 10-Q · filed 2022-07-29 | $22.30M 10-Q · filed 2022-07-29 | $34.40M derived: sum of 3 quarters · filed 2023-02-14 | $45.00M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-03-31 | $10.80M 10-Q · filed 2022-04-29 | $22.90M derived: sum of 2 quarters · filed 2023-02-14 | $33.50M derived: sum of 3 quarters · filed 2023-02-14 | $43.80M derived: sum of 4 quarters · filed 2023-02-14 |
| 2020-12-31 | $12.10M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | $22.70M derived: sum of 2 quarters · filed 2023-02-14 | $33.00M derived: sum of 3 quarters · filed 2023-02-14 | $42.20M 10-K · filed 2023-02-14 |
| 2020-09-30 | $10.60M 10-Q · filed 2021-10-29 | $20.90M derived: sum of 2 quarters · filed 2021-10-29 | $30.10M 10-Q · filed 2021-10-29 | $39.90M derived: sum of 4 quarters · filed 2022-02-11 |
| 2020-06-30 | $10.30M 10-Q · filed 2021-07-30 | $19.50M 10-Q · filed 2021-07-30 | $29.30M derived: sum of 3 quarters · filed 2022-02-11 | $31.20M derived: sum of 4 quarters · filed 2022-02-11 |
| 2020-03-31 | $9.20M 10-Q · filed 2021-04-28 | $19.00M derived: sum of 2 quarters · filed 2022-02-11 | $20.90M derived: sum of 3 quarters · filed 2022-02-11 | $69.60M derived: sum of 4 quarters · filed 2022-02-11 |
| 2019-12-31 | $9.80M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-11 | $11.70M derived: sum of 2 quarters · filed 2022-02-11 | $60.40M derived: sum of 3 quarters · filed 2022-02-11 | $64.40M 10-K · filed 2022-02-11 |
| 2019-09-30 | $1.90M 10-Q · filed 2020-10-27 | $50.60M derived: sum of 2 quarters · filed 2020-10-27 | $54.60M 10-Q · filed 2020-10-27 | $57.30M derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-06-30 | $48.70M 10-Q · filed 2020-07-29 | $52.70M 10-Q · filed 2020-07-29 | $55.40M derived: sum of 3 quarters · filed 2021-02-16 | $59.50M derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-03-31 | $4.00M 10-Q · filed 2020-04-29 | $6.70M derived: sum of 2 quarters · filed 2021-02-16 | $10.80M derived: sum of 3 quarters · filed 2021-02-16 | $13.10M derived: sum of 4 quarters · filed 2021-02-16 |
| 2018-12-31 | $2.70M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | $6.80M derived: sum of 2 quarters · filed 2021-02-16 | $9.10M derived: sum of 3 quarters · filed 2021-02-16 | $13.00M 10-K · filed 2021-02-16 |
| 2018-09-30 | $4.10M 10-Q · filed 2019-11-05 | $6.40M derived: sum of 2 quarters · filed 2019-11-05 | $10.30M 10-Q · filed 2019-11-05 | |
| 2018-06-30 | $2.30M 10-Q · filed 2019-08-06 | $6.20M 10-Q · filed 2019-08-06 | ||
| 2017-12-31 | $31.80M 10-K · filed 2020-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |